Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy
5 de abril de 2022
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
